Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lucentis
Lucentis
Lucentis biosimilar: Formycon eyes 2020 for US launch
BioPharma Reporter
Tue, 11/28/17 - 09:17 pm
Lucentis
Formycon
Genentech/Roche
FYB201
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
Biotechs line up to tap growing ophthalmics market
BioPharma Dive
Thu, 12/22/16 - 10:25 am
Ophthalmic Drugs Market
Ocular Therapeutix
Eylea
Restasis
Lucentis
Regeneron
Roche
Allergan
Ophthotech Plunges on Eye Drug Study Failure
TheStreet.com
Mon, 12/12/16 - 09:17 am
Ophthotech
clinical trials
Fovista
Lucentis
wet age-related macular degeneration
9 Drugs That Cost Medicare a Fortune
Motley Fool
Sun, 04/10/16 - 01:29 pm
Medicare
Lucentis
Eylea
Prolia
Treanda
Lexiscan
Yervoy
Privigen
Provenge
Soliris
Regeneron Eye Drug's Advantage Over Roche's Narrowed in Trial
Bloomberg
Sun, 02/28/16 - 10:52 am
Regeneron
dry eye disease
Roche
Lucentis
Eylea
Lucentis more effective than lasers for reversing diabetes-induced blindness in new study
BioPharma Dive
Tue, 11/17/15 - 01:22 pm
Lucentis
PDR
proliferative diabetic retinopathy
Roche
The Next Blockbusters Could Be Balms For Aging Eyes
Investors.com
Thu, 09/3/15 - 09:10 am
age-related macular degeneration
Bayer
Regeneron
Ophthotech
Allergan
Novartis
Applied Genetic Technologies
Avalanche Biotechnologies
Roche
Lucentis
Eylea
Eylea erodes Lucentis, Avastin market share
Medical Marketing and Media
Tue, 08/4/15 - 06:10 pm
Eylea
Lucentis
Avastin
Regeneron
Roche/Genentech
Biosimilar of Novartis' eye drug Lucentis launched in India
Fierce Pharma
Fri, 06/19/15 - 05:13 pm
Novartis
India
Lucentis
biosimilars
Pfizer Buys Your Biosimilar Partner? How Pfenex’ Heartburn Was Quickly Relieved
Informabi
Thu, 06/18/15 - 11:07 am
BIO2015
biosimilars
Pfenex
Pfizer
Hospira
Lucentis
PF582
Did Novartis try to sabotage Avastin ophthalmic trials?
BioPharma Dive
Mon, 04/6/15 - 10:54 am
Novartis
Avastin
Roche
Lucentis
BMJ: Novartis tried to 'scupper' trials to protect Lucentis from cheap Avastin
Fierce Pharma
Thu, 04/2/15 - 11:52 am
Novartis
clinical trials
Roche
Avastin
Lucentis
Ohr Pharma's eye drug fails main goal in mid-stage study
Yahoo/Reuters
Fri, 03/27/15 - 08:43 am
Ohr Pharmaceutical
OHR-102
Lucentis
wet age-related macular degeneration
UK doctors lobby for off-label Avastin use
Medical Marketing and Media
Tue, 02/24/15 - 06:59 pm
UK
Avastin
off-label
Lucentis
wet age-related macular degeneration
Roche
Novartis
Regeneron Beats Genentech In Rare Face Off Over Diabetes-Related Vision Loss
Forbes
Thu, 02/19/15 - 10:38 am
Regeneron
Genentech
diabetes
Eylea
Lucentis
DME
diabetic macular edema
Pharma Files Complaint Against Italy for Reimbursing Off-Label Prescribing
WSJ Pharmalot
Tue, 02/10/15 - 06:40 pm
Italy
off-label
Avastin
Lucentis
Roche
Novartis
Roche's blockbuster Lucentis nabs fourth FDA approval
BioPharma Dive
Mon, 02/9/15 - 06:01 pm
Roche
Lucentis
FDA
DME
diabetic macular edema
This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Motley Fool
Mon, 02/2/15 - 10:08 am
Ophthotech
Novartis
Regeneron
Fovista
Roche
Avastin
Eylea
Lucentis
wet age-related macular degeneration
Genentech's top-billing Lucentis users are also top-paid speakers: NYT
Fierce Pharma
Tue, 12/9/14 - 07:55 am
Genentech
Lucentis
physician payments
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »